See also this year's filing and all EDGAR filings for this company.
PDF Report 0001399529_2018_Dicerna_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001399529')"} |
Graph
Absolute values for 0001399529, Dicerna Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 118,558,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,512,000 |
| 3 | remainder_Assets | 814,000 |
| 4 | LiabilitiesCurrent | 16,646,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 3,000,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 25,881,000 |
| 9 | ResearchAndDevelopmentExpense | 36,983,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 2,277,000 |
| 12 | remainder_NetIncome | 539,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 120,884,000 |
| 1 | Liabilities | 19,646,000 |
| 2 | Expenses | 62,864,000 |
| 3 | Revenues | 2,277,000 |
| 4 | StockholdersEquity | 101,238,000 |
| 5 | NetIncome | -60,048,000 |
| 6 | ComprehensiveNetIncome | -60,048,000 |
| 7 | BaseVar | 103,105,000 |
| 8 | EconomicCapitalRatio | 1.62 |